Arjun Ravi
- Enhanced IL-6 and CCL3 activity in COPDBy Arjun Ravi, Shruti Khurana, Jonathan Plumb, George Booth, Matthew Catley, Emma Smith, Louise Healy, Jørgen Vestbo and Dave SinghArjun Ravi1Medicines Evaluation Unit, University of Manchester, Greater Manchester, United KingdomShruti Khurana1Medicines Evaluation Unit, University of Manchester, Greater Manchester, United KingdomJonathan Plumb1Medicines Evaluation Unit, University of Manchester, Greater Manchester, United KingdomGeorge Booth1Medicines Evaluation Unit, University of Manchester, Greater Manchester, United KingdomMatthew Catley2UCB Celltech, UCB S.A, Slough, Berkshire, United KingdomEmma Smith2UCB Celltech, UCB S.A, Slough, Berkshire, United KingdomLouise Healy2UCB Celltech, UCB S.A, Slough, Berkshire, United KingdomJørgen Vestbo1Medicines Evaluation Unit, University of Manchester, Greater Manchester, United KingdomDave Singh1Medicines Evaluation Unit, University of Manchester, Greater Manchester, United Kingdom
- Alveolar macrophages activate STAT3 in epithelial cells via gp130 dependant steroid insensitive mechanismBy Jonathan Plumb, Arjun Ravi, George Booth and Dave SinghJonathan Plumb1Institute of Inflammation and Repair, University of Manchester, Manchester, United KingdomArjun Ravi1Institute of Inflammation and Repair, University of Manchester, Manchester, United KingdomGeorge Booth1Institute of Inflammation and Repair, University of Manchester, Manchester, United KingdomDave Singh1Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom
- Impaired monocyte chemotaxis in COPDBy Arjun Ravi, Jonathan Plumb, Jonathan Lemon, George Booth, Jorgen Vestbo and Dave SinghArjun Ravi1The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester, NIHR South Manchester Respiratory and Allergy Clinical Research Facility, Manchester, United Kingdom2The Medicines Evaluation Unit, University Hospital of South Manchester, Manchester, Greater Manchester United KingdomJonathan Plumb1The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester, NIHR South Manchester Respiratory and Allergy Clinical Research Facility, Manchester, United KingdomJonathan Lemon1The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester, NIHR South Manchester Respiratory and Allergy Clinical Research Facility, Manchester, United KingdomGeorge Booth1The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester, NIHR South Manchester Respiratory and Allergy Clinical Research Facility, Manchester, United KingdomJorgen Vestbo1The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester, NIHR South Manchester Respiratory and Allergy Clinical Research Facility, Manchester, United KingdomDave Singh1The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester, NIHR South Manchester Respiratory and Allergy Clinical Research Facility, Manchester, United Kingdom2The Medicines Evaluation Unit, University Hospital of South Manchester, Manchester, Greater Manchester United Kingdom
- LATE-BREAKING ABSTRACT: A Phase 1b study of PUR0200, a novel tiotropium formulation, in COPD patientsBy David Hava, Katie Kane, Fred Reid, Arjun Ravi, Jo Collier, Tess Schmalbach and Dave SinghDavid Hava1Clinical Development, Pulmatrix Inc, Lexington, MA United StatesKatie Kane1Clinical Development, Pulmatrix Inc, Lexington, MA United StatesFred Reid2Medicines Evaluation Unit, Wythenshaw Hospital, Manchester, United KingdomArjun Ravi2Medicines Evaluation Unit, Wythenshaw Hospital, Manchester, United KingdomJo Collier3Clinical Research, Quotient Clinical, Nottingham, United KingdomTess Schmalbach1Clinical Development, Pulmatrix Inc, Lexington, MA United StatesDave Singh2Medicines Evaluation Unit, Wythenshaw Hospital, Manchester, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.